Report from the 46th annual scientific session of the American College of Cardiology, Anaheim, California, 16-19 March 1997.
Wroe
C D
CD
D000282:Administration, Intravaginal; D001741:Black or African American / Q000706:statistics & numerical data; D000789:Angina, Unstable / Q000188:drug therapy; D000959:Antihypertensive Agents / Q000627:therapeutic use; D044383:Black People; D002140:California; D002309:Cardiology; D002986:Clinical Trials as Topic; D004967:Estrogens / Q000008:administration & dosage; D006331:Heart Diseases / Q000188:drug therapy* / Q000208:ethnology / Q000401:mortality; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D010960:Plasminogen Activators / Q000627:therapeutic use; D011374:Progesterone / Q000008:administration & dosage; D012955:Societies, Medical
D000959:Antihypertensive Agents; D004967:Estrogens; D011374:Progesterone; D010960:Plasminogen Activators